New Sinclair Pharma boss invests £822,000

A round-up of the biggest director deals today so far.

Sinclair Pharma's new chief executive and two non-executive directors all increased their shareholdings after the specialist pharma company's recent fundraising.

Sinclair raised £18.2m - £16m after expenses - at 32p a share to finance the purchase of Flammazine and Flammacerium, which are creams to prevent infections in burns, from Solvay. Sinclair paid €17.5m to Solvay for the two products, which generate annual revenues of more than £9m.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.